Acute Myocardial Infarction
Conditions
Brief summary
The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.
Detailed description
In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.
Interventions
Clinical leaders and clinical personnel will regularly receive feedback regarding performance of their own hospital as well as other providers in the regional health trust of North Norway.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)
Exclusion criteria
* Reperfusion therapy not indicated or contraindicated
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to reperfusion | This parameter will be recorded within 1 week after patient inclusion | Interval between 1st medical contact and opening of the infarction-related coronary artery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ejection fraction at discharge | This parameter will be recorded up to 6 months after patient inclusion | Systolic function of the left ventricle |
| Survival | This parameter will be collected from patient's records during Nov -20 till Aug -21. | Survival after 30 days from incident |
Countries
Norway